重大事件
即時報告
8-K
2026-05-28
Quantum Cyber N.V. 提交8-K申報 披露其他事件
AI 繁中摘要
Quantum Cyber N.V.（CIK: 0001874252）於 2026年5月28日向美國證監會提交了一份 8-K 申報文件，報告日期為同一天。📄
該 8-K 僅涉及 **Item 8.01 – 其他事件**，具體事件內容未在本次公開元數據中披露。公司總部位於德國美因茨，主營藥物製劑（SIC 2834），財政年度至 12 月 31 日止。⚠️
投資者應留意：此類 8-K 通常會後續補充說明事件的性質及潛在財務影響（例如重大合約、訴訟和解、資本變動或業務重組等）。建議查閱完整申報文本（Accession No. 0001213900-26-062109）以獲取詳情。
展開英文正文
EDGAR Filing Documents for 0001213900-26-062109 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-062109 Filing Date 2026-05-28 Accepted 2026-05-28 16:05:36 Documents 11 Period of Report 2026-05-28 Items Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0292568-8k_quantum.htm iXBRL 8-K 22414 Complete submission text file 0001213900-26-062109.txt 187283 Data Files Seq Description Document Type Size 2 XBRL SCHEMA FILE qucy-20260528.xsd EX-101.SCH 3038 3 XBRL LABEL FILE qucy-20260528_lab.xml EX-101.LAB 34239 4 XBRL PRESENTATION FILE qucy-20260528_pre.xml EX-101.PRE 22374 14 EXTRACTED XBRL INSTANCE DOCUMENT ea0292568-8k_quantum_htm.xml XML 3233 Mailing Address ROBERT KOCH STRASSE 50 MAINZ Germany Business Address ROBERT KOCH STRASSE 50 MAINZ Germany 49 6131 5542860 Quantum Cyber N.V. (Filer) CIK: 0001874252 (see all company filings) EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41010 | Film No.: 261035579 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)